BLUVEAU Trademark

Trademark Overview

On Tuesday, October 25, 2011, a trademark application was filed for BLUVEAU with the United States Patent and Trademark Office. The USPTO has given the BLUVEAU trademark a serial number of 85455166. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 15, 2019. This trademark is owned by Glaxo Group Limited. The BLUVEAU trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

medical services, namely, cell and gene therapy
bluveau

General Information

Serial Number85455166
Word MarkBLUVEAU
Filing DateTuesday, October 25, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 15, 2019
Registration Number4170838
Registration DateTuesday, July 10, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 24, 2012

Trademark Statements

Goods and Servicesmedical services, namely, cell and gene therapy

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 15, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Friday, February 15, 2019CANCELLED SEC. 8 (6-YR)
Monday, July 10, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 10, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, April 24, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 24, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 4, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 16, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 8, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 29, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 29, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 28, 2012ASSIGNED TO LIE
Friday, February 10, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 12, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 12, 2011NON-FINAL ACTION E-MAILED
Monday, December 12, 2011NON-FINAL ACTION WRITTEN
Wednesday, December 7, 2011ASSIGNED TO EXAMINER
Friday, October 28, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 28, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

bluveau gene therapy cell namely services medical